These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35279480)

  • 1. Long noncoding RNA HOXD-AS1 promotes the progression of pancreatic cancer through miR-664b-3p/PLAC8 axis.
    Chen L; Niu W; Zhu D; Shao W; Qian Y
    Pathol Res Pract; 2022 Apr; 232():153836. PubMed ID: 35279480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
    Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
    J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
    Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
    Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
    Chen S; Li K
    BMC Cancer; 2020 Sep; 20(1):924. PubMed ID: 32977766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ZEB1-AS1 promotes pancreatic cancer progression by regulating miR-505-3p/TRIB2 axis.
    Wei G; Lu T; Shen J; Wang J
    Biochem Biophys Res Commun; 2020 Aug; 528(4):644-649. PubMed ID: 32513531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
    Zhang ZB; Liu N
    Aging (Albany NY); 2021 Aug; 13(16):20820-20835. PubMed ID: 34461605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN.
    Li J; Jiang X; Li Z; Huang L; Ji D; Yu L; Zhou Y; Cui Y
    Aging (Albany NY); 2020 Aug; 12(16):16304-16325. PubMed ID: 32857725
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Chi C; Mao M; Shen Z; Chen Y; Chen J; Hou W
    Hum Gene Ther; 2018 Dec; 29(12):1438-1448. PubMed ID: 29896986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA RGMB-AS1 facilitates pancreatic cancer cell proliferation and migration but inhibits cell apoptosis via miR-574-3p/PIM3 axis.
    Song W; Shi C
    Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G477-G488. PubMed ID: 34468207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis.
    Wang B; Sun X; Huang KJ; Zhou LS; Qiu ZJ
    World J Gastroenterol; 2021 May; 27(17):1993-2014. PubMed ID: 34007135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA CERS6-AS1 promotes proliferation and metastasis through the upregulation of YWHAG and activation of ERK signaling in pancreatic cancer.
    Xu J; Wang J; He Z; Chen P; Jiang X; Chen Y; Liu X; Jiang J
    Cell Death Dis; 2021 Jun; 12(7):648. PubMed ID: 34168120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA CERS6-AS1 Accelerates the Proliferation and Migration of Pancreatic Cancer Cells by Sequestering MicroRNA-15a-5p and MicroRNA-6838-5p and Modulating HMGA1.
    Shen R; Wang X; Wang S; Zhu D; Li M
    Pancreas; 2021 Apr; 50(4):617-624. PubMed ID: 33939677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204.
    Zhou H; Ma Y; Zhong D; Yang L
    Biomed Pharmacother; 2019 Apr; 112():108633. PubMed ID: 30784927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA HOXD-AS1 induces epithelial-mesenchymal transition in breast cancer by acting as a competing endogenous RNA of miR-421.
    Li Y; Han X; Li Q; Wang C; Lou Z; Wang X
    J Cell Biochem; 2019 Jun; 120(6):10633-10642. PubMed ID: 30730081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA VPS9D1-AS1 regulates miR-187-3p/fibroblast growth factor receptor-like 1 axis to promote proliferation, migration, and invasion of prostate cancer cells.
    Wu C; Chen J; Wang D
    Chin J Physiol; 2023; 66(5):295-305. PubMed ID: 37929340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HOXD-AS1 promotes oral squamous cell carcinoma by sponging miR-203a-5p.
    Zhang Y; Wang F; Yu Y
    Oral Dis; 2023 May; 29(4):1505-1512. PubMed ID: 35152529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.